Friday 17 August 2018
Contact US    |    Archive
Reuters
4 months ago

BRIEF-Knight Therapeutics Announces Canadian Regulatory Approval For Probuphine For Opioid Drug Dependence

* KNIGHT THERAPEUTICS ANNOUNCES CANADIAN REGULATORY APPROVAL FOR PROBUPHINE™ FOR OPIOID DRUG DEPENDENCE Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

BRIEF

 | 

Knight

 | 

Therapeutics

 | 

Announces

 | 

Canadian

 | 

Regulatory

 | 

Approval

 | 

For

 | 

Probuphine

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)